ALA 8.06% 14.3¢ arovella therapeutics limited

SUDA This week, page-18

  1. 4,707 Posts.
    lightbulb Created with Sketch. 230
    hi bang 57

    Good question. From the 21st August ASX Release headed Update on ArTiMist.

    Suda is targeting US or European registration and WHO Prequalification of ArTiMist prior to regional submission of CTD in Africa. The Company is co-ordinating its strategy with the WHO and MMV and plans to initiate dialogue with the FDA and EMA.

    I have assumed that the CTD has been part of the asset pack that potential suitors have access to when doing DD. However it would be good to get clarification on the status of CTD and Regulatory submissions.

    kippax
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.